Cannabinoid Derived Pharmaceuticals Industry Review Summit News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cannabinoid derived pharmaceuticals industry review summit. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cannabinoid Derived Pharmaceuticals Industry Review Summit Today - Breaking & Trending Today

Pascal Biosciences Inc.: Pascal Biosciences to Present at Cannabinoid Derived Pharmaceuticals Industry Review Summit


Pascal Biosciences Inc.: Pascal Biosciences to Present at Cannabinoid Derived Pharmaceuticals Industry Review Summit
Pascal or the
Company ) (TSXV:PAS)(OTC PINK:BIMUF), will present at the first?Cannabinoid Derived Pharmaceuticals Industry Review Summit today. Dr. Patrick Gray, CEO of Pascal Biosciences, will present advancements of Pascal s development program for treatment of glioblastoma with PAS-403. The title of his presentation is Discovery & Development of a Cannabinoid-Derived Therapeutic for Glioblastoma .
The Cannabinoid Derived Pharmaceuticals Industry Review Summit is the first European conference aimed to address challenges in the clinical development and commercialization of cannabinoids and drugs derived from cannabinoids. Based in London, this virtual conference is the premier format for presentation of ground-breaking discoveries in cannabinoid drug development. This meeting is hosting pharmaceutical experts developing therapeutics derived from can ....

City Of , United Kingdom , British Columbia , Pascal Biosciences , Patrick Gray , Patrickw Gray , Cannabinoid Derived Pharmaceuticals Industry Review Summit , Company Contact , Pascal Biosciences Inc , Discovery Development , Regulation Services Provider , Venture Exchange , Sorse Technology , Cannabinoid Derived Therapeutic , Private Securities Litigation Reform Act , நகரம் ஆஃப் , ஒன்றுபட்டது கிஂக்டம் , பிரிட்டிஷ் கொலம்பியா , பாஸ்கல் உயிர் அறிவியல் , பேட்ரிக் சாம்பல் , நிறுவனம் தொடர்பு , பாஸ்கல் உயிர் அறிவியல் இன்க் , கண்டுபிடிப்பு வளர்ச்சி , ஒழுங்குமுறை சேவைகள் வழங்குநர் , துணிகர பரிமாற்றம் , ப்ரைவேட் பத்திரங்கள் வழக்கு சீர்திருத்தம் நாடகம் ,

Cannabinoid Derived Pharmaceuticals Industry Review Summit - January 19 - 21, 2021 - GB


January 19 - 21, 2021
- GB
Hanson Wade
Phone:+442031418700
Cannabinoid derived pharmaceuticals have faced many challenges in their development. Cannabis prohibition being the original and biggest obstruction to progress. Now the industry has started facing new, more acute challenges like finding suitable patient populations and designing robust trials, working with regulators around the world with varying attitudes towards cannabis, selecting the most pharmacologically appropriate synthetic or phytocannabinoid possible just to name a few. Along with the challenges COVID-19 has created over the past months many of these other challenges have been facing the industry for years.
Introducing the first Cannabinoid Derived Pharmaceuticals Industry Review Summit, taking place virtually 19th - 21st January. Attending online will give you access to the same opportunities as a physical attendee through our purpose-built online ....

Hanson Wade , Cannabinoid Derived Pharmaceuticals Industry Review Summit , Cannabinoid Derived Pharmaceuticals Industry Review Summitjanuary , ஹான்சன் வேட் ,